Farallon Capital Management is an investment fund managing more than $14.5 trillion ran by John Warren. There are currently 130 companies in Mr. Warren’s portfolio. The largest investments include Unitedhealth Inc and Salesforce Inc, together worth $1.58 trillion.
As of 7th August 2024, Farallon Capital Management’s top holding is 1,618,200 shares of Unitedhealth Inc currently worth over $824 billion and making up 5.7% of the portfolio value.
Relative to the number of outstanding shares of Unitedhealth Inc, Farallon Capital Management owns more than approximately 0.1% of the company.
In addition, the fund holds 2,946,838 shares of Salesforce Inc worth $758 billion, whose value fell 11.9% in the past six months.
The third-largest holding is IQVIA Inc worth $618 billion and the next is Exelixis Inc worth $609 billion, with 27,102,500 shares owned.
Currently, Farallon Capital Management's portfolio is worth at least $14.5 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Farallon Capital Management office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, John Warren serves as the Managing Member at Farallon Capital Management.
In the most recent 13F filing, Farallon Capital Management revealed that it had opened a new position in
Disney Walt Co and bought 3,582,168 shares worth $356 billion.
The investment fund also strengthened its position in Salesforce Inc by buying
994,670 additional shares.
This makes their stake in Salesforce Inc total 2,946,838 shares worth $758 billion.
Salesforce Inc soared 20.1% in the past year.
On the other hand, there are companies that Farallon Capital Management is getting rid of from its portfolio.
Farallon Capital Management closed its position in Pioneer Nat Res Co on 14th August 2024.
It sold the previously owned 3,520,000 shares for $924 billion.
John Warren also disclosed a decreased stake in Unitedhealth Inc by approximately 0.1%.
This leaves the value of the investment at $824 billion and 1,618,200 shares.
The two most similar investment funds to Farallon Capital Management are Calamos Advisors and Private Advisor. They manage $14.4 trillion and $14.6 trillion respectively.
Farallon Capital Management’s portfolio is diversified across 13 sectors.
Currently, their heaviest sector is Health Care — making up 41.1% of
the total portfolio value.
The fund focuses on investments in the United States as
65.4% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
24% of the total holdings value.
On the other hand, small-cap stocks make up only 1.5% of the portfolio.
The average market cap of the portfolio companies is close to $65.2 billion.
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Pioneer Nat Res Co |
Closed
3,520,000
|
$924,000,000,000 | |
| Unitedhealth Group Inc |
4.89%
1,618,200
|
$824,084,532,000 | 5.69% |
| Salesforce Inc |
50.95%
2,946,838
|
$757,632,050,000 | 5.23% |
| IQVIA Holdings Inc |
3.06%
2,923,032
|
$618,045,886,000 | 4.27% |
| Exelixis Inc |
1.59%
27,102,500
|
$608,993,175,000 | 4.21% |
| Aramark |
5.01%
16,929,237
|
$575,932,643,000 | 3.98% |
| Aon plc. |
196.71%
1,875,200
|
$550,521,216,000 | 3.80% |
| Microsoft Corporation |
0.72%
1,202,778
|
$537,581,627,000 | 3.71% |
| New York Times Co. |
11.34%
9,919,840
|
$507,995,006,000 | 3.51% |
| Natera Inc |
13.57%
4,460,557
|
$483,033,718,000 | 3.34% |
| Nasdaq Inc |
11.02%
7,506,719
|
$452,354,887,000 | 3.12% |
| TransUnion |
4.98%
6,035,119
|
$447,564,425,000 | 3.09% |
| Intuit Inc |
17.13%
629,097
|
$413,448,839,000 | 2.86% |
| Thermo Fisher Scientific Inc. |
7.31%
739,156
|
$408,753,268,000 | 2.82% |
| Revolution Medicines Inc |
29.97%
9,757,692
|
$378,696,027,000 | 2.62% |
| Sarepta Therapeutics Inc |
6.46%
2,295,000
|
$362,610,000,000 | 2.50% |
| ServiceNow Inc |
14.92%
454,050
|
$357,187,514,000 | 2.47% |
| Disney Walt Co |
Opened
3,582,168
|
$355,673,461,000 | 2.46% |
| S&P Global Inc |
1.50%
781,934
|
$348,742,564,000 | 2.41% |
| Wabtec |
25.94%
2,189,498
|
$346,050,159,000 | 2.39% |
| CBRE Group Inc |
9.82%
3,773,000
|
$336,212,030,000 | 2.32% |
| Alphabet Inc |
46.18%
1,796,540
|
$329,521,367,000 | 2.28% |
| Boston Scientific Corp. |
10.61%
4,109,157
|
$316,446,181,000 | 2.19% |
| Analog Devices Inc. |
16.46%
1,284,800
|
$293,268,448,000 | 2.03% |
| Airbnb, Inc. |
5.77%
1,701,000
|
$257,922,630,000 | 1.78% |
| Costar Group, Inc. |
Closed
2,594,356
|
$250,614,790,000 | |
| Agios Pharmaceuticals Inc |
1.14%
5,654,502
|
$243,822,126,000 | 1.68% |
| Visa Inc |
20.71%
821,886
|
$215,720,418,000 | 1.49% |
| Full Truck Alliance Co. Ltd. |
1.65%
25,850,303
|
$207,836,436,000 | 1.44% |
| Mastercard Incorporated |
9.82%
462,771
|
$204,156,054,000 | 1.41% |
| Protagonist Therapeutics Inc |
1.77%
5,840,773
|
$202,382,784,000 | 1.40% |
| Howmet Aerospace Inc. |
25.48%
2,541,839
|
$197,322,962,000 | 1.36% |
| Sherwin-Williams Co. |
14.10%
647,550
|
$193,248,347,000 | 1.33% |
| Astrazeneca plc |
65.08%
2,409,718
|
$187,933,907,000 | 1.30% |
| Beam Therapeutics Inc. |
75.39%
7,913,123
|
$185,404,472,000 | 1.28% |
| Lantheus Holdings Inc |
53.67%
2,279,227
|
$182,999,136,000 | 1.26% |
| Centene Corp. |
16.86%
2,168,175
|
$143,750,003,000 | 0.99% |
| Masimo Corp |
24.84%
1,119,563
|
$140,997,764,000 | 0.97% |
| Inspire Med Sys Inc |
Closed
626,854
|
$134,641,971,000 | |
| New Oriental Ed & Technology |
138.96%
1,469,590
|
$114,231,231,000 | 0.79% |
| Vestis Corporation |
Closed
4,914,753
|
$94,707,290,000 | |
| Tenet Healthcare Corp. |
7.84%
687,442
|
$91,450,409,000 | 0.63% |
| Grayscale Bitcoin Tr Btc |
Closed
1,349,077
|
$85,221,194,000 | |
| Longboard Pharmaceuticals In |
No change
2,940,500
|
$79,481,715,000 | 0.55% |
| Biohaven Ltd |
181.35%
2,248,000
|
$78,028,080,000 | 0.54% |
| AMGEN Inc. |
Opened
232,000
|
$72,488,400,000 | 0.50% |
| Geron Corp. |
124.64%
16,837,000
|
$71,388,880,000 | 0.49% |
| KE Holdings Inc. |
No change
4,740,833
|
$67,082,787,000 | 0.46% |
| Icon Plc |
0.83%
178,200
|
$55,860,354,000 | 0.39% |
| Cencora Inc. |
27.31%
242,800
|
$54,702,840,000 | 0.38% |
| Cerevel Therapeutics Hldng I |
11.95%
1,190,000
|
$48,659,100,000 | 0.34% |
| Silicon Motion Technology Corp |
33.66%
567,534
|
$45,964,579,000 | 0.32% |
| United Therapeutics Corp |
30.00%
143,000
|
$45,552,650,000 | 0.31% |
| Insmed Inc |
Opened
568,000
|
$38,056,000,000 | 0.26% |
| Progyny Inc |
120.81%
1,308,500
|
$37,436,185,000 | 0.26% |
| Flutter Entmt Plc |
Opened
200,800
|
$36,617,888,000 | 0.25% |
| Evolent Health Inc |
Closed
1,037,331
|
$34,014,083,000 | |
| CRISPR Therapeutics AG |
Opened
530,000
|
$28,625,300,000 | 0.20% |
| Enanta Pharmaceuticals Inc |
No change
2,095,000
|
$27,172,150,000 | 0.19% |
| Liquidia Corp |
No change
2,055,000
|
$24,660,000,000 | 0.17% |
| Alibaba Group Hldg Ltd |
Closed
329,000
|
$23,806,440,000 | |
| Crinetics Pharmaceuticals In |
9,840.00%
497,000
|
$22,260,630,000 | 0.15% |
| Vaxcyte, Inc. |
23.16%
290,000
|
$21,897,900,000 | 0.15% |
| Apogee Therapeutics Inc |
Closed
305,000
|
$20,267,250,000 | |
| Savara Inc |
90.45%
4,560,000
|
$18,376,800,000 | 0.13% |
| Voyager Therapeutics Inc |
No change
2,292,000
|
$18,129,720,000 | 0.13% |
| Centessa Pharmaceuticals Plc |
438.01%
1,996,000
|
$18,023,880,000 | 0.12% |
| Ascendis Pharma A/S |
Closed
109,000
|
$16,477,530,000 | |
| Intra-Cellular Therapies Inc |
Closed
231,000
|
$15,985,200,000 | |
| Spyre Therapeutics Inc |
42.92%
666,000
|
$15,657,660,000 | 0.11% |
| Immunome, Inc. |
Closed
594,000
|
$14,659,920,000 | |
| TAL Education Group |
No change
1,365,000
|
$14,564,550,000 | 0.10% |
| Zymeworks Inc |
No change
1,601,000
|
$13,624,510,000 | 0.09% |
| PG&E Corp. |
45.56%
692,323
|
$12,087,960,000 | 0.08% |
| Gds Hldgs Ltd |
72.69%
1,226,133
|
$11,390,776,000 | 0.08% |
| Screaming Eagle Acquisitn Co |
Closed
1,000,000
|
$10,700,000,000 | |
| Elevation Oncology Inc |
7.42%
3,598,418
|
$9,715,729,000 | 0.07% |
| Twist Bioscience Corp |
Opened
192,000
|
$9,461,760,000 | 0.07% |
| Rio Tinto plc |
No change
137,500
|
$9,065,375,000 | 0.06% |
| Cazoo Group Ltd |
Closed
714,240
|
$8,570,880,000 | |
| Bruker Corp |
Closed
83,100
|
$7,806,414,000 | |
| Ventyx Biosciences Inc |
No change
3,170,000
|
$7,322,700,000 | 0.05% |
| Gossamer Bio, Inc. |
Closed
6,130,272
|
$7,233,721,000 | |
| Roivant Sciences Ltd |
25.11%
673,000
|
$7,113,610,000 | 0.05% |
| Tectonic Therapeutic Inc |
Opened
431,010
|
$7,098,735,000 | 0.05% |
| Helix Acquisition Corp Ii |
No change
600,000
|
$6,132,000,000 | 0.04% |
| Metals Acquisition Limited |
160.44%
410,197
|
$5,615,597,000 | 0.04% |
| Cytokinetics Inc |
No change
102,400
|
$5,548,032,000 | 0.04% |
| Metagenomi Inc |
No change
1,343,201
|
$5,480,260,000 | 0.04% |
| Novavax, Inc. |
66.64%
377,250
|
$4,775,985,000 | 0.03% |
| Ultragenyx Pharmaceutical In |
No change
99,000
|
$4,068,900,000 | 0.03% |
| Prime Medicine Inc |
No change
750,000
|
$3,855,000,000 | 0.03% |
| Cogent Biosciences, Inc. |
7.97%
425,161
|
$3,584,107,000 | 0.02% |
| Swiftmerge Acquisition Corp |
No change
300,000
|
$3,277,500,000 | 0.02% |
| Praxis Precision Medicines I |
Closed
50,000
|
$3,051,000,000 | |
| Berenson Acquisition Corp. I |
No change
285,715
|
$3,042,865,000 | 0.02% |
| Biodesix Inc |
Opened
1,878,175
|
$2,873,608,000 | 0.02% |
| Arrivent Biopharma Inc |
Closed
151,768
|
$2,710,576,000 | |
| Arya Sciences Acqu Corp Iv |
No change
200,000
|
$2,292,000,000 | 0.02% |
| Nurix Therapeutics, Inc. |
Opened
108,799
|
$2,270,635,000 | 0.02% |
| Amylyx Pharmaceuticals Inc |
No change
1,150,221
|
$2,185,420,000 | 0.02% |
| Summit Midstream Partners LP |
No change
58,214
|
$2,070,090,000 | 0.01% |
| Marblegate Acquisition Corp |
No change
150,000
|
$1,621,500,000 | 0.01% |
| VNET Group Inc |
No change
650,000
|
$1,361,750,000 | 0.01% |
| Soleno Therapeutics Inc |
Closed
27,750
|
$1,187,700,000 | |
| Quanterix Corp |
83.01%
80,000
|
$1,056,800,000 | 0.01% |
| Forte Biosciences, Inc. |
No change
1,810,455
|
$972,214,000 | 0.01% |
| Madrigal Pharmaceuticals Inc |
No change
3,319
|
$929,851,000 | 0.01% |
| Veeva Sys Inc |
Opened
3,622
|
$662,862,000 | 0.00% |
| Sage Therapeutics Inc |
No change
42,800
|
$464,808,000 | 0.00% |
| Blueprint Medicines Corp |
No change
4,000
|
$431,120,000 | 0.00% |
| Cara Therapeutics Inc |
No change
1,556,251
|
$401,513,000 | 0.00% |
| Krystal Biotech Inc |
No change
2,000
|
$367,280,000 | 0.00% |
| Axsome Therapeutics Inc |
No change
4,000
|
$322,000,000 | 0.00% |
| HCA Healthcare Inc |
No change
1,000
|
$321,280,000 | 0.00% |
| Immunovant Inc |
Opened
12,000
|
$316,800,000 | 0.00% |
| Glaukos Corporation |
No change
2,600
|
$307,710,000 | 0.00% |
| TransMedics Group, Inc. |
Opened
2,000
|
$301,240,000 | 0.00% |
| Alnylam Pharmaceuticals Inc |
Closed
2,000
|
$298,900,000 | |
| Merit Med Sys Inc |
No change
3,000
|
$257,850,000 | 0.00% |
| Encompass Health Corp |
No change
3,000
|
$257,370,000 | 0.00% |
| Brightspring Health Svcs Inc |
No change
22,000
|
$249,920,000 | 0.00% |
| Globus Med Inc |
Opened
3,600
|
$246,564,000 | 0.00% |
| SpringWorks Therapeutics, Inc. |
Closed
5,000
|
$246,100,000 | |
| Arcutis Biotherapeutics Inc |
98.54%
26,000
|
$241,800,000 | 0.00% |
| Healthequity Inc |
No change
2,800
|
$241,360,000 | 0.00% |
| Merus N.V |
Opened
4,000
|
$236,680,000 | 0.00% |
| Alpine Immune Sciences Inc |
Closed
5,900
|
$233,876,000 | |
| Apellis Pharmaceuticals Inc |
No change
6,000
|
$230,160,000 | 0.00% |
| Ionis Pharmaceuticals Inc |
99.35%
4,800
|
$228,768,000 | 0.00% |
| Humana Inc. |
98.84%
600
|
$224,190,000 | 0.00% |
| Acadia Healthcare Company In |
Closed
2,800
|
$221,816,000 | |
| Arcellx Inc |
No change
4,000
|
$220,760,000 | 0.00% |
| IDEAYA Biosciences, Inc. |
Closed
5,000
|
$219,400,000 | |
| Chemed Corp. |
No change
400
|
$217,032,000 | 0.00% |
| Sabra Health Care Reit Inc |
No change
14,000
|
$215,600,000 | 0.00% |
| Dyne Therapeutics, Inc. |
Opened
6,000
|
$211,740,000 | 0.00% |
| Iovance Biotherapeutics Inc |
No change
26,000
|
$208,520,000 | 0.00% |
| Syndax Pharmaceuticals Inc |
No change
10,000
|
$205,300,000 | 0.00% |
| Avidity Biosciences, Inc. |
99.18%
5,000
|
$204,250,000 | 0.00% |
| Hims & Hers Health, Inc. |
99.40%
10,000
|
$201,900,000 | 0.00% |
| R1 RCM Inc. |
No change
16,000
|
$200,960,000 | 0.00% |
| Canopy Growth Corporation |
Opened
30,000
|
$193,500,000 | 0.00% |
| Pacific Biosciences Calif In |
96.42%
135,000
|
$184,950,000 | 0.00% |
| Altimmune Inc |
94.13%
27,600
|
$183,540,000 | 0.00% |
| Grifols S A |
No change
28,000
|
$176,540,000 | 0.00% |
| Oscar Health, Inc. |
No change
11,000
|
$174,020,000 | 0.00% |
| Ardelyx Inc |
No change
23,000
|
$170,430,000 | 0.00% |
| Amicus Therapeutics Inc |
No change
16,000
|
$158,720,000 | 0.00% |
| C4 Therapeutics, Inc. |
No change
28,000
|
$129,360,000 | 0.00% |
| Beyond Meat Inc |
No change
19,000
|
$127,490,000 | 0.00% |
| Ironwood Pharmaceuticals Inc |
No change
13,000
|
$84,760,000 | 0.00% |
| Lufax Holding Ltd |
90.00%
15,000
|
$35,550,000 | 0.00% |
| No transactions found | |||
| Showing first 500 out of 153 holdings | |||